Spire Healthcare H1 revenue dips 0.8% as NHS activity declines
Adjusted EBITDA fell 16.6% and adjusted free cash flow rose 35.3%. The company reiterated FY26 adjusted EBITDA is targeted broadly in line with FY25.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Adjusted EBITDA fell 16.6% and adjusted free cash flow rose 35.3%. The company reiterated FY26 adjusted EBITDA is targeted broadly in line with FY25.